Blue Ocean Capital Group (“BOCG”) is a leading investment firm focusing on innovative biotech, medical device, and med-tech companies with growth and buyout strategies. Our award-winning team has vast industry experience and international insights.
Since founded in 2015, we have adopted value-driven approach and worked closely with entrepreneurs to bring meaningful impact on their businesses and ultimately create long-term value for our investors.
BOCG has become a signatory to the United Nations-supported Principles for Responsible Investment ("UN PRI") from the beginning of 2022. As a firm believer of Capital for Good, BOCG is devoted to responsible investment and empowers sustainable development of the portfolio companies.
Innovative biotech, medical device, med-tech companies
Leverage our industry know-how to support portfolio companies’ long-term growth
At the heart of our company is an expert-led team of investment professionals with significant industry and capital markets experience, international insights, and proven track record. We understand the importance of driving value in portfolio companies through operational expertise and improvement. Our dedicated team has deep industry knowledge to be valuable partners to our portfolio companies.